New research shows there are fewer asymptomatic COVID-19 cases than previously thought.

Could Europe's second wave hit harder than the first?

Stanford scientists discuss their role in the Johnson & Johnson Phase 3 vaccine trial.

To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy

Learn more about your ad choices. Visit https://podcastchoices.com/adchoices